Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2024

Download PDF
Open Webpage

Giovanni Birolo, Pietro Bosoni, Guglielmo Faggioli, Helena Aidos, Roberto Bergamaschi, Paola Cavalla, Adriano Chiò, Arianna Dagliati, Mamede de Carvalho, Giorgio Maria Di Nunzio, Piero Fariselli, Jose Manuel García Dominguez, Marta Gromicho, Alessandro Guazzo, Enrico Longato, Sara C. Madeira, Umberto Manera, Stefano Marchesin, Laura Menotti, Gianmaria Silvello et al. (6 additional authors not shown)

Published: 2024, Last Modified: 20 Apr 2026CLEF (2) 2024EveryoneRevisionsBibTeXCC BY-SA 4.0
Abstract: Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS) are two neurodegenerative diseases that cause progressive or alternating neurological impairments in motor, sensory, visual, and cognitive functions. Patients affected by these diseases undergo the physical, psychological, and economic burdens of hospital stays and home care while facing uncertainty. A possible aid to patients and clinicians might come from AI tools that can preemptively identify the need for intervention and suggest personalized therapies during the progression of these diseases.